Today, AirLife, a prominent North American manufacturer and distributor specializing in consumable medical devices for anesthesia and respiratory care (formerly known as SunMed), proudly announces the successful completion of its acquisition of Avanos Medical, Inc.'s (NYSE: AVNS) respiratory health division. This acquisition encompasses Avanos' esteemed product lines, namely BALLARD*, MICROCUFF*, and endOclear®.

This strategic move integrates three complementary brands, along with their accompanying research and development expertise, into AirLife's expanding platform. The transaction aligns with AirLife's overarching strategy to augment its leading portfolio of trusted products in the fields of anesthesia and respiratory care. It positions AirLife as a one-stop destination for premium-quality consumable breathing solutions, thereby further enabling the promotion of optimal patient outcomes.

Hank Struik, AirLife's CEO, expressed his enthusiasm, stating, "We are delighted to achieve this significant milestone in AirLife's evolution, fortifying our position as a premier, exclusively dedicated provider of consumable breathing products. We extend a warm welcome to the outstanding team that has driven the success of these industry-leading brands. With these highly trusted closed suction and endotracheal consumables, crucial for treating critically ill patients, AirLife gains fresh avenues for accelerated growth, increased support to healthcare practitioners, and the fostering of innovation within our comprehensive lineup of premier brands."

Legal counsel for AirLife in this transaction is provided by Goodwin Procter LLP.

 

Source: businesswire.com

Report Abuse